Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Becton, Dickinson and Company Stock Outperforming the Dow?

Valued at a market cap of $50.3 billion, Becton, Dickinson and Company (BDX) is a global medical technology leader based in Franklin Lakes, New Jersey. It develops, manufactures, and sells a comprehensive range of medical supplies, devices, and interventional solutions. 

Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and BDX fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the medical instruments & supplies industry. By prioritizing innovation in high-growth fields such as biologic drug delivery, automated medication management, and advanced patient monitoring, the company continues to...

Fundamentals

See More
  • Market Capitalization, $K 50,251,272
  • Shares Outstanding, K 284,742
  • Annual Sales, $ 21,840 M
  • Annual Income, $ 1,678 M
  • EBIT $ 2,675 M
  • EBITDA $ 5,137 M
  • 60-Month Beta 0.25
  • Price/Sales 2.30
  • Price/Cash Flow 7.65
  • Price/Book 1.99

Options Overview Details

View History
  • Implied Volatility 27.45% (+0.10%)
  • Historical Volatility 28.59%
  • IV Percentile 58%
  • IV Rank 42.08%
  • IV High 40.49% on 04/10/25
  • IV Low 17.97% on 08/15/25
  • Expected Move (DTE 19) 8.70 (4.93%)
  • Put/Call Vol Ratio 0.31
  • Today's Volume 106
  • Volume Avg (30-Day) 1,058
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 15,902
  • Open Int (30-Day) 21,060
  • Expected Range 167.78 to 185.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.77
  • Number of Estimates 6
  • High Estimate 2.78
  • Low Estimate 2.76
  • Prior Year 3.35
  • Growth Rate Est. (year over year) -17.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
156.45 +12.81%
on 01/29/26
187.35 -5.80%
on 02/24/26
+16.57 (+10.37%)
since 01/27/26
3-Month
148.21 +19.08%
on 12/09/25
187.35 -5.80%
on 02/24/26
+24.04 (+15.77%)
since 11/26/25
52-Week
127.59 +38.32%
on 11/06/25
187.35 -5.80%
on 02/24/26
+0.25 (+0.14%)
since 02/27/25

Most Recent Stories

More News
Is Becton, Dickinson and Company Stock Outperforming the Dow?

As Becton, Dickinson and Company has outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

BDX : 176.48 (-0.10%)
$DOWI : 48,977.92 (-1.05%)
ISRG : 503.51 (-0.66%)
How Is Stryker's Stock Performance Compared to Other Healthcare Stocks?

Despite Stryker’s underperformance relative to its peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 160.20 (+1.77%)
SYK : 387.46 (+0.36%)
BDX : 176.48 (-0.10%)
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase

FRANKLIN LAKES, N.J. , Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the " Company " or " BD "), a leading global medical technology company, today announced...

BDX : 176.48 (-0.10%)
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap

FRANKLIN LAKES, N.J. , Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the " Company " or " BD "), a leading global medical technology company, today announced...

BDX : 176.48 (-0.10%)
BD to Present at Barclays 28th Annual Global Healthcare Conference

FRANKLIN LAKES, N.J. , Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays...

BDX : 176.48 (-0.10%)
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency

The BD Vacutainer® Urine Complete Cup Kit preserves specimen quality, streamlines testing, and helps reduce repeat collections to support better patient care

BDX : 176.48 (-0.10%)
Lanesha Minnix Named General Counsel for BD

FRANKLIN LAKES, N.J. , Feb. 19, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Lanesha Minnix has been named...

BDX : 176.48 (-0.10%)
5 Must-Read Analyst Questions From BD’s Q4 Earnings Call

5 Must-Read Analyst Questions From BD’s Q4 Earnings Call

BDX : 176.48 (-0.10%)
Are Wall Street Analysts Bullish on Becton, Dickinson and Company Stock?

Becton, Dickinson and Company has lagged behind the broader market over the past year, yet analysts remain somewhat optimistic about the stock’s prospects.

XLV : 160.20 (+1.77%)
$SPX : 6,878.88 (-0.43%)
BDX : 176.48 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 182.30
2nd Resistance Point 180.15
1st Resistance Point 178.32
Last Price 176.48
1st Support Level 174.34
2nd Support Level 172.19
3rd Support Level 170.36

See More

52-Week High 187.35
Last Price 176.48
Fibonacci 61.8% 164.52
Fibonacci 50% 157.47
Fibonacci 38.2% 150.42
52-Week Low 127.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar